Visual Perceptual Learning for the Treatment of Visual Field Defect — VIVID2

Hemianopsia, Homonymous Clinical Trial

Official title:
Efficacy and Safety of Visual Perceptual Learning Using the Nunap Vision for Improvement of Visual Field Defect Caused by Brain Damage: Multi Center, Superiority Prove, Double-blind, Randomized, Confirmatory Study

Status Completed

Clinical Trial Summary

This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain damage. Half of participants will receive visual perceptual training using the Nunap Vision, while the other half will receive sham training using the Nunap Vision-C.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04102605
Study type	Interventional
Source	Nunaps Inc
Contact
Status	Completed
Phase	N/A
Start date	October 17, 2019
Completion date	May 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT00731796` - Testing of a Functional Outcome Measure for Those With Visual Field Defects	N/A
Completed	`NCT05525949` - Visual Perceptual Learning Based Digital Therapeutics for Visual Field Defect After Stroke	N/A
Recruiting	`NCT06047717` - Vision Loss Impact on Navigation in Virtual Reality	N/A
Completed	`NCT04230486` - VR System for Cross-modal Rehabilitation of Hemianopia	N/A
Recruiting	`NCT05397873` - Biofeedback for Hemianopia Vision Rehabilitation	N/A
Completed	`NCT06116760` - Anodal tDCS With Compensatory Audio-visual Training for Acquired Visual Field Defects After Brain Injury	N/A